Earlier this month, we joined the 45,000 healthcare enthusiasts at HIMSS in Las Vegas. Rather than covering the obvious themes of interoperability, blockchains or the cloud, here are some of our not-so-obvious key takeaways. The tech giants had many representatives who flew undercover – Apple had no booth. Amazon’s booth was…
Dear Clients and Friends, Some companies engage in M&A to achieve synergies or diversification, while others aim for growth or to eliminate the competition. History is full of examples of horizontal tie-ups amongst providers, insurers or pharmaceuticals. In the new era of healthcare, however, M&A is all about survival. Our…
Dear Clients and Friends, Please see below for our October HIT Market Update. According to PhRMS, it takes 10 years and $2.6 billion to bring a drug to market and only two out of ten approved medications produce revenues that exceed their R&D costs. Many expect the picture to worsen in the…
There is a saying that “In God we trust… but all others must bring data”. We agree. Without data, we trust no one. And we want analytics too. But even that is not always enough because those who crunch data in healthcare sometimes cannot deliver contextual precision. Here are a…